https://sciex.com/content/SCIEX/na/us/en


Mass Spectrometry Detects Very Low Levels of Chemical Compounds in Asia Pacific Waters

Aug 5, 2015 | Blogs, Food / Beverage | 0 comments

Did you know that even though most of the world is covered in water, access to clean drinkingwater remains a problem?  Take Asia for example where 62,000 people have lost their lives between 2001 and 2005 due to water-related disaster and illness.

Clean water is easier said than done, however, as more than a thousand chemical contaminants threaten our supply. Commercial waste, runoff and groundwater discharge including pollution from human waste, industrial use, and agriculture remain a problem.  How then can we help world health organizations get a better handle on this epidemic?  Improved sanitation helps, but so too does more advanced testing technology and SCIEX is in on the solution. A recent study by our scientists experimented with sample preparation and data processing according to EPA Method 537.

Want to Know Which Method for Testing Water Quality Came out on Top? Hands-down, it is mass spectrometry (MS) because of its ability to detect very low levels of a variety of chemical compounds. These range from pesticides and pharmaceuticals and personal care products (PPCP) to residual explosives and disinfection by-products. 

A single test, just one, is all it takes to discover what lurks in drinking water when using MS.  Imagine how many people could be saved from water-borne illnesses if world health organizations were able to adopt more advanced technology. If you are someone who is interested in uncovering how mass spectrometry can help advance water testing or know someone who is, read the full report.  

Read About Additional Water Studies  > 

Questions and answers to help improve your mycotoxin analysis

During a recent webinar I shared method details for mycotoxin analysis on the SCIEX 7500 system. In this blog i will share the Q&A for the submitted questions that we did not have chance to answer during the live webinar.

A 2-fold revolution: MS approaches for the bioanalysis of oligonucleotide therapeutics

In 1998, the US Food and Drug Administration (FDA) approved fomivirsen as the first therapeutic oligonucleotide therapeutic. This approval marked a revolution of mechanism of action discovered decades before finally coming to fruition. Since then, the landscape of chemical modifications of oligonucleotides, conjugations and formulations has evolved tremendously, contributing to improvements in stability, efficacy and safety. Today, more than a dozen antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) drugs are on the market, most of which are designated as orphan drugs for treating rare genetic diseases.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial